文献速递心律失常

RyR2变异所致钙释放缺乏综合征的临床与功能特征

Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome.
PubMed 文献 · JAMA Cardiol · 2022-01-01

这项多中心观察性队列研究对10个携带超罕见RyR2变异的先证者进行功能鉴定,发现6个为功能缺失变异,符合钙释放缺乏综合征(CRDS)。CRDS患者运动负荷试验常无复杂室性心律失常,与CPVT不同;随访中19例确诊CRDS患者有10例发生至少1次危及生命事件。

要点

  • RyR2功能缺失变异可致CRDS,表现为室颤风险但运动负荷试验常无复杂室性心律失常。
  • CRDS患者室颤可由自发性长爆发-长间歇-短联律样异位搏动序列诱发。
  • CRDS与CPVT机制和表型不同,临床识别困难,需更好诊断工具和治疗。

核心结论

  • RyR2功能缺失变异所致CRDS在机制和表型上不同于CPVT,室颤可由自发性LBLPS样异位搏动序列诱发,但临床识别仍困难。

研究设计与样本

  • 多中心观察性队列研究,纳入10个不明原因危及生命心律失常事件且携带超罕见RyR2变异的先证者,变异在HEK293细胞中经咖啡因刺激进行功能鉴定。
  • 数据收集自2012年9月1日至2021年3月6日,分析自2015年8月9日至2021年3月6日。

主要发现

  • 10个先证者中6个为功能缺失变异,符合CRDS,其中4例(67%)男性、2例(33%)女性,就诊中位年龄22岁(IQR 8-34)。
  • 5例有明确触发因素的先证者中3例为儿茶酚胺驱动;运动负荷试验中3例CRDS先证者无心律失常,1例有单形性二联律,2例无法进行(已故)。
  • 筛查3个家系后13名亲属诊断为CRDS,其中3例(23%)有既往心律失常事件,运动负荷试验均无复杂室性心动过速。
  • 19例确诊CRDS患者中10例在就诊时和/或中位随访7年(IQR 6-18)期间发生至少1次危及生命事件;3次设备检测到的室颤中2次由自发性LBLPS样序列诱发。
  • 17例存活患者中16例(94%)使用β受体阻滞剂;16例报告依从β受体阻滞剂的患者中3例(19%)发生突破性事件。

关键数值与推荐

  • 6个功能缺失变异为p.E4451del、p.F4499C、p.V4606E、p.R4608Q、p.R4608W和p.Q2275H,符合CRDS。
  • CRDS患者运动负荷试验无复杂多形/双向室性心动过速,不同于CPVT。
  • LBLPS电生理方案可可靠诱发CRDS室性心律失常。

临床怎么用

  • 对不明原因危及生命心律失常事件患者应警惕RyR2功能缺失变异所致CRDS,即使运动负荷试验阴性。
  • β受体阻滞剂是CRDS患者常用治疗,但部分依从患者仍可发生突破性事件。
  • CRDS临床识别困难,需更好的诊断工具和治疗手段。

局限性

  • 样本量小,CRDS相关疾病谱数据有限。
  • 部分先证者已故无法进行运动负荷试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Calcium-release deficiency syndrome (CRDS), which is caused by loss-of-function variants in cardiac ryanodine receptor 2 (RyR2), is an emerging cause of ventricular fibrillation. However, the lack of complex polymorphic/bidirectional ventricular tachyarrhythmias during exercise stress testing (EST) may distinguish it from catecholaminergic polymorphic ventricular tachycardia (CPVT). Recently, in the first clinical series describing the condition, mouse and human studies showed that the long-burst, long-pause, short-coupled ventricular extra stimulus (LBLPS) electrophysiology protocol reliably induced CRDS ventricular arrhythmias. Data from larger populations with CRDS and its associated spectrum of disease are lacking. OBJECTIVE: To further insight into CRDS through international collaboration. DESIGN, SETTING, AND PARTICIPANTS: In this multicenter observational cohort study, probands with unexplained life-threatening arrhythmic events and an ultrarare RyR2 variant were identified. Variants were expressed in HEK293 cells and subjected to caffeine stimulation to determine their functional impact. Data were collected from September 1, 2012, to March 6, 2021, and analyzed from August 9, 2015, to March 6, 2021. MAIN OUTCOMES AND MEASURES: The functional association of RyR2 variants found in putative cases of CRDS and the associated clinical phenotype(s). RESULTS: Of 10 RyR2 variants found in 10 probands, 6 were loss-of-function, consistent with CRDS (p.E4451del, p.F4499C, p.V4606E, p.R4608Q, p.R4608W, and p.Q2275H) (in 4 [67%] male and 2 [33%] female probands; median age at presentation, 22 [IQR, 8-34] years). In 5 probands with a documented trigger, 3 were catecholamine driven. During EST, 3 probands with CRDS had no arrhythmias, 1 had a monomorphic couplet, and 2 could not undergo EST (deceased). Relatives of the decedents carrying the RyR2 variant did not have EST results consistent with CPVT. After screening 3 families, 13 relatives were diagnosed with CRDS, including 3 with previous arrhythmic events (23%). None had complex ventricular tachyarrhythmias during EST. Among the 19 confirmed cases with CRDS, 10 had at least 1 life-threatening event at presentation and/or during a median follow-up of 7 (IQR, 6-18) years. Two of the 3 device-detected ventricular fibrillation episodes were induced by a spontaneous LBLPS-like sequence. β-Blockers were used in 16 of 17 surviving patients (94%). Three of 16 individuals who were reportedly adherent to β-blocker therapy (19%) had breakthrough events. CONCLUSIONS AND RELEVANCE: The results of this study suggest that calcium-release deficiency syndrome due to RyR2 loss-of-function variants mechanistically and phenotypically differs from CPVT. Ventricular fibrillation may be precipitated by a spontaneous LBLPS-like sequence of ectopy; however, CRDS remains difficult to recognize clinically. These data highlight the need for better diagnostic tools and treatments for this emerging condition.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Roston TM, Wei J, Guo W, et al. Clinical and Functional Characterization of Ryanodine Receptor 2 Variants Implicated in Calcium-Release Deficiency Syndrome. JAMA Cardiol. 2022. PMID: 34730774. doi:10.1001/jamacardio.2021.4458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。